Table 4.

Highly Frequent Cited Papers in the Nanoparticles in Pancreatic Cancer

No.	Articles	Frequency, n	Percentage, %	Cumulative Percentage, %
1	Burris HA, 1997, J Clin Oncol, V15, P2403	66	0.1014	0.1014
2	Von Hoff DD, 2013, New Engl J Med, V369, P1691	62	0.0953	0.1966
3	Matsumura Y, 1986, Cancer Res, V46, P6387	61	0.0937	0.2904
4	Peer D, 2007, Nat Nanotechnol, V2, P751	56	0.0860	0.3764
5	Cabral H, 2011, Nat Nanotechnol, V6, P815	55	0.0845	0.4609
6	Olive KP, 2009, Science, V324, P1457	49	0.0753	0.5362
7	Jain RK, 2010, Nat Rev Clin Oncol, V7, P653	47	0.0722	0.6084
8	Lee GY, 2013, ACS nano, V7, P2078	44	0.0676	0.6760
9	Patra CR, 2008, Cancer Res, V68, P1970	44	0.0676	0.7436
10	Maeda H, 2000, J Control Release, V65, P271	42	0.0645	0.8081
11	Provenzano PP, 2012, Cancer Cell, V21, P418	42	0.0645	0.8726
12	Conroy T, 2011, New Engl J Med, V364, P1817	41	0.0630	0.9356
13	Meng H, 2015, ACS nano, V9, P3540	41	0.0630	0.9986
14	Hidalgo M, 2010, New Engl J Med, V362, P1605	40	0.0615	1.0601
15	Davis ME, 2008, Nat Rev Drug Discov, V7, P771	39	0.0599	1.1200
16	Ferrari M, 2005, Nat Rev Cancer, V5, P161	36	0.0553	1.1753
17	Fang J, 2011, Adv Drug Deliver Rev, V63, P136	35	0.0538	1.2290
18	Erkan M, 2012, Nat Rev Gastro Hepat, V9, P454	32	0.0492	1.2782
19	Li DH, 2004, Lancet, V363, P1049	31	0.0476	1.3258
20	Siegel R, 2014, CA-Cancer J Clin, V64, P9	31	0.0476	1.3735